Halozyme to Participate in the 8th Annual Evercore Healthcare Conference

Accessibility StatementSkip Navigation SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the 8th Annual Evercore Healthcare Conference. The presentation is scheduled for Tuesday, December 2 at 10:20am PT / 1:20pm ET. A live audio webcast will be available on the Investor Relations section of the Company's website. Replays of the audio webc ...